Biohaven teams up with Cove for Nurtec ODT

Biohaven Pharmaceutical Holding (NYSE:BHVN) has collaborated with Cove, a specialized care and access company for migraine sufferers via telemedicine services in the U.S.

The collaboration aims to further expand patients’ access to migraine treatments, like NURTEC ODT (rimegepant), an orally disintegrating tablet for acute treatment of migraine in adults.

Existing offerings include a two-dose complementary sample pack available with a prescription from healthcare providers, a patient starter kit and a co-pay card.

https://seekingalpha.com/news/3558897-biohaven-teams-up-cove-for-nurtec-odt

Hologic pulls 2020 guidance amid COVID-19

Hologic (NASDAQ:HOLX) is withdrawing its Q2 and FY 2020 guidance, in response to COVID-19 pandemic.

The Company expects Q2 total revenues of $756.1M (-7.6% Y/Y).

Q2 Diagnostics and Breast Health revenues of $319.2M and $307.8M, respectively.

Q2 GYN Surgical revenue of $105.4M.

The company expects to report Q2 results on April 29.

https://seekingalpha.com/news/3558907-hologic-pulls-2020-guidance-amid-covidminus-19

Futures extend rally, ahead by 3%

Stock futures are pointing to another opening jump in early morning trade, up nearly 3%, following a steep rebound in the previous session that saw major U.S. indexes rally more than 7%.

In a press conference Monday, President Trump said there’s “tremendous light at the end of the tunnel” with ten different therapeutic agents in active trials amid a slew of coronavirus headlines pointed to a potential stabilization in the U.S.

The Federal Reserve also moved to bolster a new small business lending program by allowing financial institutions to turn those loans over to the U.S. central bank for cash.

https://seekingalpha.com/news/3558857-futures-extend-rally-ahead-3

Inovio to start coronavirus vaccine safety test in Philly, Kansas City

A second U.S. company is poised to begin a small safety test of a vaccine against the new coronavirus.

Inovio Pharmaceuticals said Monday that it has Food and Drug Administration permission for the study in 40 healthy volunteers in Philadelphia and Kansas City, Mo.

The study is a first step to see if the vaccine appears safe enough for larger tests needed to prove whether it will protect. Even if the research goes well, it is expected to take over a year before any vaccine could be widely available.

Last month, the first safety test in people of a different vaccine candidate began in Seattle. It was developed by the National Institutes of Health and Moderna Inc.

Numerous other research groups are attempting to make vaccines against COVID-19 using a variety of different methods in hopes at least one will offer protection.
https://www.inquirer.com/health/coronavirus/coronavirus-covid-19-vaccine-testing-philadelphia-kansas-city-20200406.html

CytoDyn to supply leronlimab to UK COVID-19 patients

CytoDyn (OTCQB:CYDY) is collaborating with the U.K.’s Department of Health to provide emergency access to leronlimab, an investigational medicine for COVID-19.

The submission to Medicines and Healthcare Products Regulatory Agency (MHRA) is expected soon to include clinical trial sites in the U.K.

U.K. representatives are coordinating with CytoDyn’s international clinical research organization, Amarex Clinical Research, to prepare the requisite clinical agreements and to prepare for timely delivery of leronlimab.

The FDA has cleared the Company to initiate a Phase 2b/3 clinical trial COVID-19 patients for which enrollment is now underway.

https://seekingalpha.com/news/3558860-cytodyn-to-supply-leronlimab-to-uk-covidminus-19-patients

‘U.S. is past the peak, economy to reopen shortly’ – JPMorgan

Sounding more bullish about the outlook than anyone out there, JPMorgan says the U.S. passed its peak in new cases three or four days ago, and expects a limited reopening of the economy in one-to-two weeks.

Noting global stocks down about 35% on average, they are overweight equities. While acknowledging the horrendous near-term economic hit, the team says investors will be focusing on 2021, and even 2022.

As for winners going forward, they note every recession accelerates pre-existing trends – in this case things like working from home and online retail.

Some related ETFs: USA, CRF, SCHX, ZF, VV, FEX, JKD, SFY, EEH, EQL, IWL, GSEW

https://seekingalpha.com/news/3558890-u-s-is-past-peak-economy-to-reopen-shortly-jpmorgan

Chester County is first in PA to initiate COVID-19 antibody testing

Officials in Chester County, Pennsylvania announced a plan to undertake antibody testing of priority individuals who are currently performing essential functions in the fight against COVID-19. This is the first in the Commonwealth to undertake such a test.
“We have just received a shipment of 10,000 blood test kits and are expecting a second shipment of 10,000 more next week. These kits will be administered to priority individuals – emergency responders, healthcare workers and staff at long-term care facilities throughout Chester County, to determine those who have developed coronavirus antibodies, with or without symptoms,” said Chester County Commissioners’ Chair Marian Moskowitz.
When a person gets infected by a particular germ, the body starts making specially designed proteins called antibodies to fight the infection. After the person recovers, those antibodies float in survivors’ blood — specifically plasma, the liquid part of blood – for months, even years.
The tests are just another weapon in the county’s arsenal to fight the coronavirus.
“This test is supplemental to the coronavirus testing that we have already been doing and will continue to do,” said Jeanne Casner, Chester County Health Department Director. “It is not a replacement test for confirming cases.
The county purchased the antibody test kits from Advaite, a Chester County-based company. Test results are available within 15 minutes.
The first level priority testing will begin this week.
Chester County Commissioner Michelle Kichline said, “As we review the results of the antibody blood tests, we will work with first responders, hospitals and long-term care facilities to determine how the results can best be used to manage this crisis. It is our intention to continue sourcing more of the blood test kits. The more we have, the more people we can test to get a fuller picture of how many have had COVID-19 in Chester County, either knowingly or unknowingly.”
Officials say the antibody test will not require the use of personal protection equipment required by first responders, healthcare workers and staff at long-term care facilities.
To date, three Chester County residents have died from the virus. A total of 304 cases have been confirmed in the county.
https://6abc.com/health/chester-co-to-initiate-covid-19-antibody-testing-for-essential-workers/6081721